Drugs / AMG 114
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT00119600 | — | anemia, cancer | Amgen | Terminated | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | AMG 114 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00119600 ↗ |
| Route | Subcutaneous | “AMG 114 administered subcutaneously” NCT00119600 ↗ |